Market Introduction
Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities that are capable of specific interactions represents a significant challenge in the early stages of drug discovery. When the biological target is well defined and understood, the rational design of small molecule ligands is possible. In the recent years, the small molecules have witnessed significant attention over biologics, as there is an increasing demand for these drugs.
Market Overview and Dynamics
The Europe small molecule drug delivery market is expected to reach US$ 13,381.71 million by 2027 from US$ 6,835.97 million in 2019. The market is expected to grow with a CAGR of 9.0% from 2020 to 2027. Factors such as growing demand for R&D from contract organizations along with the growing developments and start-ups in small molecules drug delivery market is likely to propel the growth of the market. However, high cost associated with drug development is the major factor hindering the market growth.
Key Market Segments
In terms of therapeutic area, the oncology segment held the larger share of the market in 2019. However, rare diseases is anticipated to register the higher CAGR in the market during the forecast period. Based on process/phase, in 2019, the lead generation and refinement segment held the larger share of the market, however, target discovery segment is anticipated to register the higher CAGR in the market during the forecast period.
Major Sources and Companies Listed
Some of the major primary and secondary sources for Europe small molecule drug delivery market included in the report are European Investment Bank (EIB), World Health Organization (WHO), National Center for Biotechnology Information (NCBI), and National Heart, Lung, and Blood Institute (NHLBI)
Reasons to buy the report
Europe Small Molecule Drug Delivery Market –
By Therapeutic Area
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 6,835.97 Million |
| Market Size by 2027 | US$ 13,381.71 Million |
| CAGR (2020 - 2027) | 9.0% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Therapeutic Area
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Small Molecule Drug Delivery Market is valued at US$ 6,835.97 Million in 2019, it is projected to reach US$ 13,381.71 Million by 2027.
As per our report Europe Small Molecule Drug Delivery Market, the market size is valued at US$ 6,835.97 Million in 2019, projecting it to reach US$ 13,381.71 Million by 2027. This translates to a CAGR of approximately 9.0% during the forecast period.
The Europe Small Molecule Drug Delivery Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Small Molecule Drug Delivery Market report:
The Europe Small Molecule Drug Delivery Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Small Molecule Drug Delivery Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Small Molecule Drug Delivery Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Small Molecule Drug Delivery Market
